SixPeaks Bio AG
Targeting Muscle to Provide Healthy Weight Loss
At SixPeaks Bio we believe that protection of lean tissue mass will be a core component for future healthy weight management solutions. We are targeting preservation and potentially an expansion of skeletal muscle mass as a future therapeutic companion to GLP1 RAs.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
10.11.2025
AstraZeneca acquires SixPeaks for up to USD 300 million (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
SixPeaks Bio AG
Targeting Muscle to Provide Healthy Weight Loss
Website:
sixpeaksbio.com/
Acquired by:
AstraZeneca
AstraZeneca
Headquarter:
Basel
Foundation Date:
July 2022
Technology:
- Biotech